Dudediligence.

Aktis Oncology, Inc

AKTSNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

53.4M

on 2026-06-30, from 915K on 2025-12-31 10-Q ↗

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

None

No at-the-market programme on file in the last 30 months.

Warrants

The 10-Q filed 2026-08-13 is not read yet.

Cash

Four quarters of operating cash flow to 2026-06-30 are not all on file.

Raised
DateWhatSharesPriceGrossFiling
2026-01-08Public offering17,650,000$18.00not read424B4 ↗